日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome

使用双肠促胰岛素激动剂 DA-CH5 治疗对 Wolfram 综合征大鼠模型显示出有效的治疗效果

Toomas Jagomäe, Nayana Gaur, Kadri Seppa, Riin Reimets, Marko Pastak, Mihkel Plaas, Allen Kaasik, Eero Vasar, Mario Plaas

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

在沃尔夫拉姆综合征大鼠模型中,早期干预和终身使用GLP-1受体激动剂利拉鲁肽治疗,重点关注视觉神经退行性变、感觉神经性听力损失和糖尿病表型

Jagomäe, Toomas; Seppa, Kadri; Reimets, Riin; Pastak, Marko; Plaas, Mihkel; Hickey, Miriam A; Kukker, Kaia Grete; Moons, Lieve; De Groef, Lies; Vasar, Eero; Kaasik, Allen; Terasmaa, Anton; Plaas, Mario

Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model

利拉鲁肽、7,8-二氢叶酸及其联合治疗可预防沃尔夫拉姆综合征大鼠模型中的视力丧失和认知功能下降。

Seppa, Kadri; Jagomäe, Toomas; Kukker, Kaia Grete; Reimets, Riin; Pastak, Marko; Vasar, Eero; Terasmaa, Anton; Plaas, Mario

Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation

基因疗法用于调节角膜移植引起的T细胞介导的免疫反应

Pastak, Marko; Kleff, Veronika; Saban, Daniel R; Czugala, Marta; Steuhl, Klaus-Peter; Ergün, Süleyman; Singer, Bernhard B; Fuchsluger, Thomas A